Recent Advances in Microneedle Technology for Transdermal Drug Delivery

Figure 1:Transdermal Drug Delivery

2.1.1    Application of the Drug Formulation

The process begins when a transdermal system (such as a patch, cream, gel, or microneedle array) is placed on the skin.

The system contains the active drug along with excipients (like permeation enhancers or stabilizers) that help in controlled drug release.

The drug must be in a form that allows it to dissolve and diffuse through the layers of the skin.

2.1.2    Contact with the Stratum Corneum (Main Barrier)

Stratum corneum is the outermost layer of the epidermis and acts as the primary barrier to penetration.

It is made up of dead, keratinized cells (corneocytes) embedded in a lipid matrix often described as a “brick and mortar” structure.

Because of this dense and water-resistant structure, only small, lipophilic (fat-soluble) and non-ionized molecules can naturally pass through easily.

Therefore, this step determines how much drug can actually begin to move into the body.

2.1.3    Penetration Pathways Across the Skin

Once the drug encounters the stratum corneum, it can enter through three main routes:

1.         Transcellular (through the cells):

The drug passes directly through the corneocytes and lipid layers. Requires both water and lipid solubility for efficient transport.

2.         Intracellular (between the cells):

The drug diffuses through the lipid channels between cells. This is the most common and important route for most drugs.

3.         Appendageal (through skin appendages):

The drug enters through hair follicles, sweat glands, and sebaceous glands.

Through these cover a small area, they are useful for delivering larger molecules or rapid onset drugs.

2.1.4    Diffusion Through the Viable Epidermis

Once past the stratum corneum, the drug reaches the viable epidermis, which is composed of living cells but lacks blood vessels.

Here, the drug continues to diffuse passively through cell layers, driven by the concentration gradient (from high concentration at the skin surface to low concentration inside).

The epidermis acts as a rate-controlling layer in drug transport.

2.1.5    Passage into the Dermis

After the viable epidermis, the drug reaches the dermis, a thicker layer (~2 mm) rich in connective tissue, nerves, lymphatics, and capillaries.

The dermis does not significantly hinder drug movement.Once the drug diffuses into the capillary network, it can enter systemic circulation or act locally in the skin.

2.1.6    Absorption into the Bloodstream

From the dermal blood vessels, the drug enters the systemic circulation, distributing throughout the body to reach its target tissues.

The absorption rate depends on factors such as:

°Drug concentration and formulation

°Skin thickness and hydration

° Body site of application (thinner skin = faster absorption)

° Duration of application

2.1.7    Controlled and Sustained Release

Most transdermal systems are designed to release the drug slowly and steadily over hours or even days. This provides consistent plasma drug levels, avoiding the peaks (toxicity) and troughs (inefficacy) often seen with oral or injectable routes. Controlled release also improves patient compliance, as fewer doses are needed.

2.1.8    Avoidance of First-Pass Metabolism

Drugs delivered through the skin bypass the gastrointestinal tract and liver, meaning they avoid first-pass metabolism. This increases bioavailability and allows for lower doses to achieve the same effect.It also benefits patients with swallowing difficulties or gastrointestinal side effects.

2.1.9    Role of Permeation Enhancement Techniques

To overcome the strong barrier of the stratum corneum, enhancement strategies are often used:

Chemical Enhancers: Alcohols, fatty acids, surfactants, and terpenes temporarily disrupt lipid structure to increase permeability.

Physical Methods:

Microneedles: Create microscopic pores in the skin to allow larger molecules to pass Iontophoresis: Uses a mild electric current to push charged drug molecules through the skin. Sonophoresis: Uses ultrasound waves to enhance penetration.

Thermal methods: Slightly heat the skin to increase permeability

2.1.10  Pharmacological Action:

Once in the bloodstream, the drug reaches its site of action and exerts its therapeutic effect.

Alternatively, for local delivery systems (like pain patches), the drug may act directly on tissues beneath the application site.

2.1.11  Final Elimination:

After performing its function, the drug is metabolized and excreted via normal physiological pathways (liver and kidneys), just like drugs delivered by other routes.2

3.         Classification & Types of Microneedle Systems

Microneedles are classified based on their structure and mechanism of drug delivery:

•           Solid Microneedles: Used to create microchannels followed by application of a drug patch (“poke and patch”)2,3

Solid microneedles can be used to prepare the skin for drug delivery. They are briefly inserted and then removed, creating tiny, microscopic pores on the skin’s surface — a process known

as the “poke and patch” approach. These microchannels allow drugs to pass more easily through the skin and reach the deeper layers, improving absorption.

Research on rat skin has shown that when the treated area is kept covered (for example, with an occlusive tape), the tiny pores can remain open for up to 72 hours after microneedle application. However, if the skin is left uncovered, the pores close much more quickly. Importantly, these microchannels heal rapidly — typically within about two hours — which helps minimize the risk of infection.9

•           Coated Microneedles: Drugs are coated onto the microneedle surface and delivered upon insertion (“coat and poke”)2,4

•           Hollow Microneedles: Serve as microinjectors, delivering liquid formulations through their lumen (“poke and flow”)10,11.

•           Dissolving/Degradable Microneedles: Made from biodegradable polymers that dissolve in the skin, releasing the drug (“shove and release”)12–14 .

•           Hydrogel-Forming Microneedles: Absorb interstitial fluid, swelling to form a drug- conductive pathway; can also extract fluid for diagnostics12,15 .

Each type offers unique advantages and challenges in terms of fabrication, drug loading, and patient outcomes.

Figure 2: Mechanism of Action: microneedle technology for transdermal drug delivery

Table 1: A detailed list of advantages, disadvantages and method of delivery of various MNs

4.         Materials & Fabrication Techniques

4.1       Materials Used

Polymers: Both natural (e.g., gelatin, chitosan) and synthetic (e.g., PVP, PLA, PLGA) polymers are widely used due to their biocompatibility and biodegradability12–14 .

Metals: Stainless steel and titanium offer excellent mechanical strength but lack biodegradability3,16.

Ceramics and Composites: Offer high mechanical strength but are more brittle and complex to fabricate11 .

4.2       Fabrication Methods

° Micromolding: Most common, scalable, and cost-effective method for polymer MNs17.

°Photolithography and Laser Etching: High precision, ideal for silicon and metal MNs 18.

°3D Printing: Innovations such as vat polymerization and two-photon polymerization allow customized MN arrays with complex geometries 18,19..

Recent advances focus on improving reproducibility, reducing production costs, and enabling the use of novel, stimuli-responsive materials6,7,19 .

Figure 3: Methods of Fabrication of Microneedle technology for transdermal drug delivery

5.         Functional Enhancements & Smart Features

Modern microneedle systems often integrate advanced functionalities:

Controlled/Sustained Release: Layered or encapsulated designs allow for time-controlled delivery of drugs3,13.

Stimuli-Responsive Systems: Respond to pH, temperature, or light for targeted release7,8.

Smart Systems: Integration with biosensors allows real-time monitoring and closed-loop drug delivery (e.g., insulin pumps for diabetes)7,19.

Enhanced Mechanical Properties: Advanced materials and geometric designs ensure reliable skin penetration and adhesion18,20.

These enhancements make microneedles suitable for precision medicine and theranostic applications.

6.         Safety, Biocompatibility, and Skin Response

Insertion Mechanics: MNs are generally pain-free due to shallow skin penetration. Needle geometry and force directly influence pain and efficacy 3,6,20.Biocompatibility:        Most    polymeric       microneedles  are       safe     and            non-immunogenic. Biodegradable MNs reduce infection risk by leaving no residual sharp waste4,12.

Long-Term Effects: Studies suggest minimal skin irritation and no significant long-term adverse effects when properly fabricated and sterilized 4,13.

Nonetheless, safety must be assessed for each new material and formulation to ensure clinical acceptability.

7.         Characterization and Testing Methods

Mechanical Testing: Includes fracture force, insertion force, and penetration depth. These are tested in synthetic skin models and ex vivo tissues17,20.

Drug Release & Permeation:

In Vitro: Franz diffusion cells evaluate drug permeation across skin samples13. In Vivo: Microdialysis techniques measure drug levels in interstitial fluid4,15.

Such rigorous testing ensures consistent performance, safety, and therapeutic efficacy.

8.         Applications

1.    Vaccines: Microneedles offer dose sparing, thermostability, and improved compliance for vaccines like influenza, anthrax, and COVID-196,8,9.

2.    Biologics Delivery: Effective for insulin, GLP-1 analogs, and other peptides or proteins16,19 .

3.    Chronic Disease Management: Long-acting delivery systems for diseases like diabetes and hypertension6,19.

4.    Wound Healing: MNs with embedded nanomaterials enhance tissue regeneration, angiogenesis, and antimicrobial activity8.

5.    Local Therapies: Targeted treatment of skin diseases and superficial tumors2,12.

6.    Diagnostics: Hydrogel MNs can sample interstitial fluid for real-time biomarker analysis 8,15.

7.         Cosmetics: Used for skin rejuvenation and anti-aging therapies, often in combination with hyaluronic acid12 .

9.         Case Studies / Examples of Novel Systems

Iron Nanoparticle Patch: A microneedle patch for anemia offering sustained iron release over several days8 .

3D Printed Dissolving MNs: Customizable for drug loading and shape, showing promise for public health applications18,19 .

Wound Healing MNs: Integration of nanomaterials like silver or zinc oxide to accelerate healing and reduce infection 8.

These case studies highlight the translational potential of MN systems for real-world healthcare challenges.

10.       Challenges & Limitations

1.    Mechanical Strength vs. Penetration: Balancing strength with skin compatibility remains a challenge 18,20.

2.    Drug Loading: Limited space on or within MNs for large molecules like antibodies11,16.

3.    Skin Variability: Differences in skin type, hydration, or disease status affect performance 3,20

4.    Stability: Sensitive drugs may degrade during storage or under heat/moisture 8,9

5.    Biocompatibility Concerns: Material selection is critical to avoid immune responses

12,13.

6.    Manufacturing Scalability: Cost-effective, reproducible mass production is still being optimized17 .

7.    Regulatory Hurdles: Unclear pathways delay clinical translation and approval 6.

11.  Future Perspectives / Directions

1.    Standardization: Need for uniform testing protocols to compare across devices .

2.    Smart MN Systems: Development of real-time responsive and closed-loop devices .

3.    Hybrid MNs: Combining therapy and diagnostics for personalized healthcare .

4.    Improved Materials: High-loading, stable materials to enhance delivery of biologics.

5.         Customization: Patient-specific patches for better therapeutic targeting .

6.         Regulatory Clarity: Streamlined approval processes can accelerate clinical adoption .

7.         The future of microneedle technology lies in intelligent systems, hybrid designs, and clinical personalization.6,7.

Table 2: Drugs Used In Microneedle Technology